STAT

OCTOBER 31, 2023

But Public Citizen maintains Medicare officials should consider the ongoing cost of the patenting tactics when negotiating a price. Here’s the backstory: Enbrel was the centerpiece of a 2002 deal in which Amgen acquired another company called Immunex that had developed the medicine.

Drug Pricing 330

Drug Pricing 330

European Pharmaceutical Review

SEPTEMBER 14, 2023

Market uncertainty Rising operational costs, stiffening competition, ongoing patent expirations, evolving environmental and social governance requirements and increasing pressure on drug prices mean the industry will have to navigate thoughtfully to be successful amid this complicated mix of financial and strategic risks.

Drug Development 98

Drug Development Drug Pricing Communication 98

pharmaphorum

FEBRUARY 18, 2021

Drug prices to plummet in wave of expiring patents”. Price decay after loss of brand exclusivity”. These are just three headlines that come up when you Google “drug patent expiry”. 6 The stakes were extremely high, with annual costs of insulin reaching $736 per patient in 2013, up threefold since 2002.

Prescription Filling 52

Prescription Filling Drug Pricing Biosimilars Compounding 52

pharmaphorum

APRIL 7, 2022

But are price caps the best way to secure access to medicines, or does America have a more systemic problem? Democrat Joe Biden was elected partly on a promise to lower drug costs, in a country with among the highest prescription drug prices in the world. Right now, it takes over $2,000 out-of-pocket a month,” she said.

Diabetes 52

Diabetes Drug Pricing 52

Safe Biologics

APRIL 25, 2023

By Michael Reilly, Executive Director, Alliance for Safe Biologic Medicines (ASBM) ASBM recently submitted comments to the Centers for Medicare & Medicaid Services (CMS) on the proposed Medicare Drug Price Negotiation Plan. First, the policy itself has built-in-problems. 2 Furthermore, cancer death rates per 100,000 are 1.6

Drug Pricing 130

Drug Pricing Biosimilars Vaccines 130

Safe Biologics

APRIL 25, 2023

By Michael Reilly, Executive Director, Alliance for Safe Biologic Medicines (ASBM) ASBM recently submitted comments to the Centers for Medicare & Medicaid Services (CMS) on the proposed Medicare Drug Price Negotiation Plan. First, the policy itself has built-in-problems. 2 Furthermore, cancer death rates per 100,000 are 1.6

Drug Pricing 130

Drug Pricing Biosimilars Vaccines 130